GWPH - GW Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2018-09-29
2017-09-29
2016-09-29
Total Revenue
11,645
12,737
11,036
13,440
Cost of Revenue
6,622
5,986
4,744
3,543
Gross Profit
5,023
6,751
6,292
9,898
Operating Expenses
Research Development
141,907
153,736
149,011
130,059
Selling General and Administrative
167,400
141,818
55,863
25,981
Total Operating Expenses
309,307
295,554
204,874
156,039
Operating Income or Loss
-304,284
-288,803
-198,581
-146,142
Interest Expense
1,224
1,249
998
225
Total Other Income/Expenses Net
-2,495
-4,963
-6,759
34,085
Income Before Tax
-303,533
-291,370
-204,173
-112,282
Income Tax Expense
90
3,797
-27,754
-29,337
Income from Continuing Operations
-303,623
-295,167
-176,419
-82,945
Net Income
-303,623
-295,167
-176,419
-82,945
Net Income available to common shareholders
-303,623
-295,167
-176,419
-82,945
Reported EPS
Basic
-
-10.56
-6.98
-3.67
Diluted
-
-10.56
-6.98
-3.67
Weighted average shares outstanding
Basic
-
27,828
25,286
22,573
Diluted
-
27,828
25,286
22,573
EBITDA
-
-279,513
-195,779
-107,279